Top Markets
Coin of the day
Arctic Bioscience AS Arctic Bioscience AS

Arctic Bioscience AS

ABS
Rank in Stocks #33048
Arctic Bioscience AS, a clinical-stage biotechnology company, engages in... Arctic Bioscience AS, a clinical-stage biotechnology company, engages in developing and commercializing pharmaceutical and nutraceutical ingredients based on bioactive marine compounds in Norway, the United States, Europe, and Asia Pacific. The company is developing HRO350, a novel oral drug which is in phase IIb for the treatment of mild-to-moderate psoriasis. It also sells nutraceuticals as intermediary and finished goods products under the ROMEGA brand name. Arctic Bioscience AS was incorporated in 2011 and is headquartered in Ørsta, Norway.
Share Price
$0.3144463
Market Cap
$8.48M
Change (1 day)
0.00%
Change (1 year)
-2.55%
Country
NO
Trade Arctic Bioscience AS (ABS)

Category

P/B ratio for Arctic Bioscience AS (ABS)
P/B ratio as of 2026 TTM: 0
According to Arctic Bioscience AS latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Arctic Bioscience AS from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
6.3419 -
US
6.2413 -
NL
- -
CH
- -
KR
3.4612 -
BE